Haberman Pharma is proud to offer innovative solutions to 21st century global Emerging Infectious Diseases (EIDs) and novel drug development strategies -- from drawing board to clinical trials to the manufacturing plant.
We possess a diverse array of physicians, scientists, government collaborators and global actors (ie CROs) to provide cutting-edge consulting and development services for modern-day diseases.